ASM News
New Journal
Highlights Eukaryotic Microorganisms
Starting this month, the Society will begin
reviewing manuscripts for a new journal devoted to lower
eukaryotic microorganisms. The journal, entitled Eukaryotic
Cell, will debut on a bimonthly basis in February 2002.
"This journal will attempt to represent the
best of basic research on eukaryotic microbes that has general
significance in furthering our understanding of these
organisms," says C. C. Wang, Professor of Pharmaceutical
Chemistry at the University of California, San Francisco and
editor-in-chief of Eukaryotic Cell. "It will focus
on using modern experimental techniques and concepts to obtain
an in-depth knowledge of molecular regulatory mechanisms
involved in the growth, development, and differentiation of
eukaryotic microorganisms."
Specifically, the new journal will present
reports of basic research on simple eukaryotic microorganisms
such as yeasts, fungi, algae, protozoa, and social amoebae.
Topics will include, but are not limited to:
Basic biology
Molecular and cellular biology
Mechanisms, and control, of developmental pathways
Structure and form inherent in basic biological processes
Cellular architecture
Metabolic physiology
Comparative genomics, biochemistry, and evolution
Population dynamics
Ecology
In addition, the journal will consider
manuscripts dealing with the viruses of these organisms and
their organelles and with interactions with other living
systems, where the focus is clearly on the eurkaryotic cell.
The genesis of this publication began several
years ago, with a number of observations by some members of the
Society that pointed to potential growth in the field of
eukaryotic microbiology and an unmet need that the Society might
fulfill.
"ASM appears to get a very small
cross-section of members who are in the community of scholars
who work with eukaryotic microorganisms," says Sam Kaplan,
chair of the ASM Publications Board. "If you look at our
member roster you see that there are not very many." In
addition, the General Meeting does not get a large
representation from this community, and while the Journal of
Bacteriology does have a section on eukaryotic microbiology,
it has been relatively small and not very broad or deep in terms
of its coverage, he says. "Those are shortcomings that
existed on our part."
"In addition, coverage in other journals
was scattered. There was no single publication of focus bringing
together what is similar and different about these organisms
from a molecular, evolutionary, and developmental sense,"
says Kaplan.
The potential audience for such a publication
continues to grow. "With the era of genomic sequencinggenomes
of fungi, algae, and protozoans continue to come onlinethis
area of microbiology is going to blossom. So the time seemed
ripe," says Kaplan. Therefore the Society initiated a
three-step analysis to gauge interest in the journal.
 |
| Wang |
First, the Society contacted well-known and
respected individuals in the field of eukaryotic microbiology
and informally polled them. Although most were generally
reluctant to support yet another journal, they could see a need
for a journal on this subject if it was done properly.
"They felt that the reputation of ASM and its journals was
high enough that it would be done properly," says Kaplan. A
representative subset of those scientists polled was then
brought to ASM Headquarters to participate in a workshop where
they settled on a name and scope statement. Next, the Society
conducted a broad survey, with participants representing
research fields of model microorganisms. Approximately 80% of
respondents thought there was a need for a journal focusing on
eukaryotic cells.
"From all three data collections (informal
poll, workshop, and survey) there was a unanimity of opinion
that ASM's journals program was of such high quality that should
we undertake this journal it would be done properly," says
Kaplan. "Based on the results, it was decided to present
the journal to the ASM Leadership for permission to go
ahead." It was approved by Council Policy Committee and
Council at the 2001 General Meeting in Orlando.
What makes this new journal unique among its
peers is its scope, which covers the full continuum of
eukaryotic microorganisms. "The main purpose is for reports
on all the eukaryotic microorganisms to share the same forum, to
allow comparison, and to encourage collaboration among
researchers in the field," says Wang. The editorial board
intends to keep the journal's topics balanced to allow for a
broad cross-section of research on a variety of species and
experimental systems.
Journal of Bacteriology
Manuscripts are currently being reviewed for the
inaugural issue, which is scheduled for February 2002. As of
September 2001 the Journal of Bacteriology will no longer
be accepting manuscripts on eukaryotic microbiology and will
forward any such manuscripts received after that time to Eukaryotic
Cell with the permission of the authors.
In addition to Editor-in-Chief Wang, the board
of editors includes Jay C. Dunlap, Dartmouth Medical School,
Hanover, N.H.; Ursula W. Goodenough, University of Washington,
St. Louis, Mo.; Ching Kung, University of Wisconsin-Madison;
Adam Kuspa, Baylor College of Medicine, Houston, Tex.; and Aaron
P. Mitchell, Columbia University, New York, N.Y.
25th Anniversary
of the ICAAC Lecture
Celebrating its 25th year, the ICAAC Lectureship
honors a distinguished scientist who has made significant
contributions in the fields of infectious diseases and/or
chemotherapy. Recipients of the past decade include Barry
Marshall for his work on Helicobacter pylori, Nobel Prize
laureate Stanley Prusiner, U.S. Surgeon General David Satcher,
and Stanley Falkow, who later became the president of ASM. Their
work exemplifies commitment to the study of established and
emerging infectious diseases.
ICAAC
Community
 |
| Aguzzi |
Adriano Aguzzi is presenting this year's 41st
ICAAC Lecture, entitled "Prions: Health Scare and
Biological Challenge" on Sunday evening, 23 September. He
was selected by the ICAAC Program Committee from 15
internationally renowned nominees. Aguzzi is a highly regarded
member of the scientific community, holding a position as the
Associate Dean for Research at the University of Zurich Medical
School in Switzerland and serving on several boards, including
the Consortium for Plasma Science. His research has lead to many
important discoveries, most notably in the battle against mad
cow disease. Readers are invited to visit icaac
community for details of a premeeting interview.
41st ICAAC
Program Committee Awards
Sponsored by ASM and administered by the ICAAC
Program Committee, the Program Committee Awards were established
to encourage and recognize research excellence through
outstanding abstract preparation. This year, 3,050 abstracts
were reviewed, and the selected abstracts reflect quality
research conducted with exhaustive data analysis and of major
importance to the field. The six recipients in the following
interdisciplinary areas will be awarded a cash prize of $1,500
on Sunday evening, 23 September preceding the ICAAC Lecture.
Pathogenesis of Microbial Diseases. David B.
Weiner, University of Pennsylvania, Philadelphia; The West Nile
Virus Capsid Induces Apoptosis In Vitro and In Vivo through the
Mitochondrial Based Pathway
Epidemiology of Infection. Nina Singh, VA
Medical Center, Pittsburgh, Pa.; Staphylococcus aureus Rectal
Carriage and Association with Infections in Intensive Care Unit
(ICU) and Liver Transplant Unit Patients.
Therapy of Microbial Diseases. Joseph Gal,
University of Colorado School of Medicine, Denver;
Stereoselectivity of CYP3A4 Inhibition and Antifungal Activity
of the Enantiomers of Ketoconazole.
Clinical Microbiology and Diagnostics. Jay
C. Butler, Centers for Disease Control and Prevention,
Anchorage, Alaska; Latent Class Analysis (LCA) Evaluation of
Sputum PCR for Diagnosis of Pneumococcal Pneumonia.
Resistance: Mechanisms and Consequences. Jesus
Blazquez, Hospital Ramon y Cajal, Madrid, Spain; ß-Lactams
Induce dinB (Error-Prone DNA-Polymerase IV) Transcription
in Escherichia coli, Resulting in a Mutator Phenotype.
Immunology of Infection. Sebastiaan Weijer,
Academic Medical Centre, Amsterdam, the Netherlands; Platelet
Activating Factor Receptor Deficient (PAFR-/-) Mice Demonstrate
Diminished Neutrophil Recruitment and Impaired Bacterial
Clearance during Escherichia coli Peritonitis, yet Are
Protected against Lethality.
www.ICAAC.org
Launched during the 40th ICAAC, this ASM website
currently serves as an entry point to the scientific program and
logistics of the annual Interscience Conference on Antimicrobial
Agents and Chemotherapy. Elissa Klein Sireuil, the ICAAC Program
Manager, developed the site with the goals of offering an
informational resource 365 days a year to the ASM and ICAAC
communities, and extending educational opportunities, and
thereby facilitating health care delivery. Between 1 August and
1 September, questions were accepted for the Meet-the-Experts
sessions, and selected answers will be posted this fall. In
October, ASM will webcast the three evening lectures: Saturday's
HIV/AIDS Keynote Session, Sunday's ICAAC Lecture on prions, and
Monday's Aventis Pharamaceuticals Award Lecture on antifungal
chemotherapy. Please visit http://www.icaac.org
for current
offerings. We welcome feedback as to what features would be
important to you in the future.
ICAAC Young Investigator Awards
 |
| Fowler |
The ICAAC Young Investigator Awards, proudly
sponsored by Merck U.S. Human Health since 1983, were
established to encourage and reward young investigators residing
in North America for scientific promise and demonstrated
excellence in microbiology and infectious disease research. This
year's awards will be presented to Vance G. Fowler, Jr.,
M.D., MHS, and Paula Ivonne Watnick, M.D., Ph.D., at the
41st ICAAC in Chicago.
Fowler earned his M.D. in 1993 at the University
of North Carolina, Chapel Hill, and completed his postgraduate
training in internal medicine and infectious diseases, as well
as a Master of Science in biometry, at Duke University Medical
School, Durham, North Carolina, in 1999. While still a junior
resident, Fowler became leader of the Staphylococcus aureus
Bacteremia Group, and over the next six years compiled the
world's largest database of more than 1,000 patients with S.
aureus bacteremia. He has examined many aspects of
staphylococcal disease and made important contributions to
understanding both the pathogenesis and clinical consequences of
the important gram-positive pathogen. His investigations of the
virulence mechanisms of S. aureus include the description
of in vitro resistance to thrombin-induced platelet microbicidal
protein among clinical bacteremic isolates. In other work,
Fowler has analyzed the risk of complications of S. aureus
infection in patients with prosthetic joints.
An assistant professor in the Division of
Infectious Diseases, Department of Medicine, Duke University
Medical School for just over a year, Fowler has more than 35
peer-reviewed papers to his credit. He has recently been awarded
a K23 grant from the National Institutes of Health (NIH),
funding a five-year continuation of his research. Fowler is also
the recipient of several awards for achievement by junior
faculty including the 2001 American Federation for Medical
Research Junior Physician-Investigator Award. He was nominated
for the ICAAC Young Investigator prize by John Hamilton, M.D.,
Duke University Medical Center.
 |
| Watnick |
Paula Watnick boasts a unique educational
background and an innovative research style that have resulted
in important contributions to the understanding of bacterial
evolution and the emergence of new pathogens. She earned her
Ph.D. in biophysical chemistry at the California Institute of
Technology, Pasadena, before deciding to study medicine at Yale
University, New Haven, Conn. She then undertook postdoctoral
work in microbiology and infectious diseases at Harvard
University and Massachusetts General Hospital, and she is
currently assistant professor, Tufts University School of
Medicine, Division of Geographic Medicine and Infectious
Disease, New England Medical Center, Boston, Mass.
For the past six years, Watnick has researched
the environmental survival of V. cholerae. She first
focused on the mechanism of action of Fur, a repressor of iron
scavenging pathways in iron-rich environments, and later
initiated a genetic analysis of V. cholerae biofilm
formation, identifying structures required for biofilm
formation. Biofilm formation is an integral part of the
lifestyle of V. cholerae both within the human intestine
and the aquatic environment. Watnick's work has defined the
environmental signals and regulatory genes that control the way V.
cholerae attaches to surfaces. Her studies present new
directions for the development of methods for dispersing or
inhibiting biofilms. As such, Watnick's work has implications
for the control of cholera and less obvious applications, such
as options for the nonsurgical treatment of implanted medical
device-related infections.
A past recipient of the Howard Hughes
Postdoctoral Fellowship and the Warren-Whitman-Richardson
Fellowship, Watnick was nominated for this award by David
Snydman, M.D., of New England Medical Center.
The Aventis Pharmaceuticals Award
 |
| Dismukes |
William E. Dismukes, M.D., Director,
Division of Infectious Diseases, Vice-Chairman, Department of
Medicine, and Professor of Microbiology and Medicine, University
of Alabama School of Medicine, has been named laureate of ASM's
premier award in antimicrobial chemotherapy, the Aventis
Pharmaceuticals Award. Established in 1986, the Aventis
Pharmaceuticals Award honors sustained accomplishment in
research toward the development of new antimicrobial agents, the
investigation of action or resistance, and the pharmacology,
toxicology, or clinical use of those agents.
Dismukes has dedicated an impressive career to
establishing the scientific basis for the antimicrobial
chemotherapy of invasive fungal infections and has had a
profound impact on the lives of countless patients and the field
of clinical mycology as a whole. He was nominated for the award
by Peter G. Pappas of the University of Alabama at Birmingham,
and will present the Aventis Pharmaceuticals Award Lecture,
"Antifungal Chemotherapy: from Amphotericin B to the
Future," at the upcoming 41st annual ICAAC in Chicago, Ill.
A member of the American Association of
Physicians, a Fellow of the American Academy of Microbiology and
the Infectious Disease Society of America, and a Master of the
American College of Physicians, Dismukes has been leader of the
NIH/NIAID Mycoses Study Group (MSG) antifungal clinical trials
for more than 20 years. He has directed a group of investigators
representing more than 50 institutions with a $13-million budget
to study innovative approaches to diagnosis and management for
the invasive mycoses. In a role that combines administration
with extensive involvement in protocol design, study
interpretation, and statistical analysis, he is credited with
leadership that has set the standard for antifungal chemotherapy
clinical trials and provided the framework that guides
physicians in the treatment of these complicated infections.
Members of the MSG have recently written Infectious Disease
Society of America guidelines for the treatment of all invasive
fungal diseases.
Dismukes has been a primary investigator in a
variety of areas including the initial trials that established
current first-choice therapies for the treatment of cryptococcal
meningitis in non-HIV-infected patients and the use of
fluconazole as an agent in the management of cryptococcal
meningitis among patients with AIDS. In the first and largest
randomized drug trials to date, Dismukes and the MSG evaluated
ketoconazole, itraconazole, and fluconazole for the treatment of
histoplasmosis and blastomycosis in both HIV-infected and
non-HIV patients, and subsequently established first-choice drug
treatment for both disorders in non-life threatening situations.
A dedicated mentor and committed role model,
Dismukes has been honored by trainees and faculty as the Best
Teacher, Outstanding Clinical Faculty, and Outstanding Clinical
Professor of the University of Alabama School of Medicine more
than 10 times. A native of Alabama, Dismukes graduated from the
University of Alabama, Tuscaloosa, and the Medical College of
Alabama. He joins the 2000 Aventis Pharmaceuticals Award
laureate Richard Whitley, M.D., to become the second remarkable
physician scientist from the University of Alabama, Birmingham,
to receive the prize.
ASM Accepted into
Official Working Relations with PAHO
The Executive Committee of the Pan American
Health Organization (PAHO), meeting for its 128th annual session
in June 2001, approved a proposal from ASM to become an official
nongovernmental organization partner of PAHO.
The ASM proposal, submitted by the International
Committee, consisted of a four-year workplan developed in
collaboration with two technical units within PAHO, the
Laboratory and Blood Services Program, and the Communicable
Diseases Program/Antimicrobial Resistance Program. The purpose
of the collaboration is to strengthen epidemiological prevention
and surveillance systems throughout Latin America and the
Caribbean, with special emphasis on emerging and reemerging
infectious diseases and antibiotic resistance.
In the initial, two-year phase of the program
(2001-2002), ASM will draw upon its extensive and diverse
membership to assist Latin American public health services in
their efforts to improve the accuracy and efficiency of
infectious disease surveillance systems. ASM and PAHO will
launch an intensive "Training of Trainers" effort to
assist Latin American laboratories to define and master testing
standards and techniques that will ensure high levels of
accuracy and consistency in the identification of emerging and
reemerging diseases and the determination of antimicrobial
resistance. ASM will actively participate in PAHO's Technical
Advisory Group to write and disseminate a set of guidelines for
antibiotic use to reduce the selective pressure that promotes
the emergence of antimicrobial resistance. Once national
laboratories have begun defining and initiating new practices
internally, ASM will organize hands-on workshops in the United
States at which national public health laboratory leaders from
Latin America will visit key U.S. institutions (such as the
Centers for Disease Control and Prevention, the National
Institutes of Health, or leading universities) to consult on
methods for creating surveillance systems within their own
countries.
In addition to these initiatives aimed at
increasing the efficacy of public health infrastructures, ASM
will work with PAHO on an educational outreach program to adapt
and translate into Spanish numerous ASM-published materials,
such as CUMITECHs, reports, studies, and videos, and to
distribute them to universities throughout Latin America. These
new educational programs will be supported by ASM's
International Professorship and International Fellowship
Programs, which offer opportunities for meaningful exchanges of
knowledge and techniques between North and South American
researchers and students.
The second phase of the PAHO/ASM collaboration
(2003-2004) will focus on consolidating and expanding the gains
achieved in phase one, and in linking national public health
programs into a continent-wide epidemiological surveillance
system.
Curriculum
Guidelines for Microbiology Majors: Recommendations
In an effort to provide guidance in the
education of undergraduate students in microbiology, ASM has
developed a set of core themes that should be addressed in every
introductory microbiology course. These guidelines have proven
useful in the development of the curriculum for many diverse
programs that may include a single course in microbiology as a
requirement. However, no such guidelines exist for departments
or programs that offer degrees specializing in microbiology. ASM
is often the first place contacted for such information when
programs are reviewing their curricula or are undergoing major
department reviews. A major goal for the 200 attendees of the
2000 Undergraduate Education Conference was to begin to develop
curriculum guidelines for microbiology majors. Based on the
recommendations of three working groups, a preliminary set of
guidelines was produced and published in the Spring 2001 Focus
on Microbiology Education newsletter. All Division W
(Microbiology Education) members were alerted to this issue of
the newsletter, which received 4,800 visitor sessions. Three new
working groups then reviewed these recommendations at the 2001
Undergraduate Education Conference. A few of the group members
were also in the groups that made the original recommendations,
but the majority of the group members were new. Thus, these
recommendations have had extensive review by a large cadre of
experienced educators. We welcome any feedback that the
microbiology community can provide for improving them.
The guidelines are not meant to be a set of
criteria for accreditation of a program. Rather, they are meant
to be used by programs in their own assessment, maintenance, and
formation of strong programs in microbiology. The
recommendations assume a semester-based academic calendar. The
lists are presented as courses for simplicity. We are not making
a specific recommendation about how a program is structured. It
may, for example, decide to integrate the equivalent content
material into several courses rather than offer them each as
individual defined units.
The list of core courses (see box) is composed
of courses recommended by all groups. The inclusion of
laboratories, or their equivalents as perhaps separate labs, for
the core courses (except the Capstone course) is highly
recommended. The list of elective courses (see box) includes
courses placed in this category by all groups, as well as some
courses that were included in the core list by at least one
group. Supporting courses that should be included in a program
of study are also listed (see box).
In addition to the core courses, the groups
developed a list of skills thought to be important for the
microbiology major. These include general research skills (e.g.,
microscopy, media preparation, anaerobic technique, and use of
diagnostics) and communication skills (both oral and written).
Basic computing skills (word processing and presentation to
spread sheet) are assumed, but the use of computers in genome
analysis and bioinformatics should be included as an integral
part of the core courses. An elective course in bioinformatics
should be available.
Two of the elective courses (Bioethics and
Careers in Microbiology) could be integrated into core course
material to ensure exposure of all students to the topics. Many
students seem to lack a clear understanding of career choices in
microbiology. More emphasis needs to be placed on educating the
students about the opportunities available to them as
microbiologists and how to get there. Bioethics is extremely
importantespecially today, because it applies to all areas in
biologyand thus inclusion of a bioethics course as an
elective in any biology program is appropriate.
A major problem noted was time and resources.
The list is long, and it is not possible to fit all of these
courses into a 4-year program; nor are all courses appropriate
for all students. A critical component to this issue may be
getting the students into the major early. The Introduction to
Microbiology course should be designed so that it can be taken
no later than the fourth semester (end of second year) of study.
This will allow for two years of advanced study of microbiology.
Another issue is the recommendation that the
core courses all have labs. However, laboratory courses are
cost-intensive. How can departments with limited resources deal
with this resource problem? One suggestion is to offer a
two-semester sequence of independent lab courses that teach the
skills needed to be a microbiologist rather than offer a lab
with every course. This may reduce the current recommendation of
five lab courses in the core curriculum to two semesters of
independent lab courses that cover the basic skills and one
advanced course with laboratory.
Please review the proposed guidelines and
provide us with feedback. I know that as a department currently
in the process of redefining our curriculum for majors,
information on program expectation is extremely valuable.
Board
of Education and Training
For more information about curriculum guidelines
for a microbiology majors program, please refer to the website
at. If you would like to send
your comments about these guidelines, send an e-mail to educationresources@asmusa.org
and place in the subject line
"curriculum guidelines."
Neil R. Baker
Neil R. Baker is Chair of the Undergraduate Education
Committee of ASM.
Membership
Awards
 |
| Rose |
The National Water Research Institute (NWRI)
awarded Joan Rose with the Athalie Richardson Irvine
Clarke Prize for excellence in water research on 25 July 2001 in
Costa Mesa, Calif. Rose is the eighth scientist, and the first
woman, to receive the prize. The Clarke Prize was established in
1993 to award scientists and engineers for outstanding work and
implementation of research in the fields of water science and
technology. Rose received a gold medallion and $50,000.
Regarded as one of the world's foremost
authorities on the dangerous waterborne microorganism Cryptosporidium,
Rose has made significant and groundbreaking advances in
understanding water quality and protecting public health. A
professor at the University of South Florida since 1989, she was
the first person to present a method for detecting Cryptosporidium
and was the principle investigator in a survey of this
deadly pathogen in surface water supplies in the United States.
Among her many achievements, Rose has also advised Congress
during the reauthorization of the Safe Drinking Water Act, was
instrumental in changing wastewater management in the Florida
Keys, and was named as one of the 21 most influential people in
water in the 21st century by Water Technology Magazine.
Presently, she is examining how climate factors may impact water
quality and public health. Rose is currently serving as Branch
Member at Large on the ASM Council Policy Committee.
Diana Downs, Associate Professor in the
Department of Bacteriology at the University of
Wisconsin-Madison, received the 21st Century Scientist Award for
Complex Systems Analysis award from the James S. McDonnell
Foundation. Downs, a microbial physiologist, received $450,000
in direct costs over a five-year period to study the complexity
of a living cell by using a bacterial cell as a model.
The goal of the award is to allow investigators
to develop and pursue novel, innovative research programs to
generate the knowledge needed to solve emerging global and
international problems. The grants are intended to encourage
investigators to engage difficult problems and to provide
support for ideas and approaches that might depart from the
conventional wisdom. The award typically funds proposals that,
because of their novelty or interdisciplinary nature, would not
be viable candidates for support from traditional sources. The
McDonnell Foundation was established in 1950 by the late James
S. McDonnell, Jr., founder of McDonnell Aircraft Corporation, to
support scientific, educational, and charitable causes. Its
primary interests are in the biomedical and behavioral sciences.
Charles L. Duncan, Vice President of
Research and Development at Hershey Foods, delivered the 10th
annual Frazier Memorial Lecture in Food Microbiology at the
University of Wisconsin-Madison in conjunction with the annual
meeting of the Food Research Institute. Duncan's lecture,
"Reflections," focused on the changes in foodborne
illnesses over the last 25 years and approaches implemented by
the food industry and regulatory agencies to control the
problem. Duncan received his Ph.D. in bacteriology from the
University of Wisconsin-Madison in 1967. After two years of
postdoctoral work, Duncan joined the faculty of the Food
Research Institute in 1969 and then went on to join the Campbell
Soup Company as director of microbiology research before moving
to Hershey Foods in 1985. The Frazier Memorial Lecture is given
annually to perpetuate the memory of William C. Frazier, a
pioneering food/dairy microbiologist at the University of
Wisconsin-Madison.
Deceased Members
Roger M. Cole died of a heart ailment on 12
February 2001 at the Mariner Health Nursing Home in Bethesda,
Md. Roger is survived by his wife, Margaret (Peggy), whom he
married in 1944, three sons, two daughters, a sister, and six
grandchildren.
Roger was born in 1917 in Canton, Maine, and
grew up in Marblehead, Mass. He performed his undergraduate
studies at the University of Massachusetts in Amherst. He
received a Master's degree in biology in 1941 and a doctorate in
microbiology in 1943, both from Harvard University. In 1947, he
received a medical degree from Boston University School of
Medicine. Roger came to the Washington, D.C., area in 1948 as a
microbiologist at the National Institute of Health (NIH) and
eventually became a Medical Director in the U.S. Public Health
Service. In 1967, he became chief of the Laboratory of
Microbiology in the National Institute of Allergy and Infectious
Diseases (NIAID), and later served a period as acting scientific
director, NIAID, and chief of the Laboratory of Streptococcal
Diseases before retiring from the U.S. Public Health Service and
NIH in 1981.
His early research was on streptococci, and he
published more than 40 papers on these organisms and their
disease relationships. In 1967, his interests turned to
bacteriophage infections, to L-forms (especially in
streptococci), and to basic studies on the ultrastructure of
various microbes and their cell walls.
He developed a great interest in mycoplasmas in
early 1972 when the first helical mycoplasma (spiroplasma) was
cultivated from plants with citrus stubborn disease by
microbiologists and plant pathologists in Bordeaux, France.
While the new organism (later designated Spiroplasma citri)
was being examined in Bethesda, Roger's expertise in electron
microscopy and microbial ultrastructure provided the opportunity
to develop techniques that would preserve the true helicity of
the organism and help to reconfirm the absence of bacterial cell
wall. During this study he was able to observe three
morphologically distinct spiroplasma viruses. In collaboration
with the French workers, he published an extensive paper on the
ultrastructure and virus infections of S. citri. Much of
Roger's later work concerned the characterization and
description of the various viruses in Spiroplasma and Mycoplasma
species, including the first observation of the P1 virus in Mycoplasma
pulmonis.
Just before his retirement, Roger had a very
active and productive collaboration with a number of groups,
including those at the University of North Carolina in Chapel
Hill and the University of Texas Health Science Center in San
Antonio. His efforts related to the use of electron microscopy
to demonstrate the role of the P1 surface protein on Mycoplasma
pneumoniae. With his collaborators, he demonstrated that
with immunoferritin electron microscopy and a monospecific
antiserum to P1, virulent and cytadhering strains of M.
pneumoniae concentrated the P1 adhesin at the terminal
organelle, while avirulent, noncytadhering strains either showed
no concentration of P1 at the terminal structure or revealed a
random distribution of P1 along the surface of the mycoplasma
membrane. These studies were critical in confirming the nature
of the M. pneumoniae attachment structure and the role of
P1 at the terminal organelle. In the summer of 1980, just before
his retirement, two strains of a new mycoplasma from patients
with nongonococcal urethritis (Mycoplasma genitalium)
were isolated in the Bethesda laboratory, and Roger's expertise
in electron microscopy was important in establishing the
ultrastructure of the isolates and documenting the
cytopathogenicity of the isolates. In 1982, he was elected an
Honorary Member of the International Organization for
Mycoplasmology.
Roger was an active participant in ASM, having
served on the editorial boards of Infection and Immunity and
Antimicrobial Agents and Chemotherapy. In 1975 he served
as chair of the Ultrastructural Division, and he was a frequent
lecturer on bacterial ultrastructure at meetings in the United
States and Europe. Roger also was active in the Research Fellows
Program in NIAID and trained many physicians on streptococcal
disease who went on to become established faculty members in
university infectious disease departments.
Joseph G. Tully
Germantown, Md.
Joel B. Baseman
Dept. of Microbiology
University of Texas Health Science Center, San Antonio
Gary B. Calandra
AnorMed Langley, B.C., Canada
David L. Williamson
Nesconset, N.Y.
Josy M. Bove
Bordeaux, France
Neal B. Groman, Professor Emeritus of the
Department of Microbiology at the University of Washington, died
on 31 March of carcinoma of the pancreas. After service in World
War II, he returned to the University of Chicago to complete his
undergraduate education, graduating with a B.S. degree in
biochemistry in 1947. He continued in graduate school under the
supervision of James Moulder and received his Ph.D. in
bacteriology and parasitology in 1950. He then moved to the
University of Washington, Seattle, with an appointment as
instructor in the Department of Microbiology, where he spent the
next 39 years of his active career, being appointed Professor
Emeritus in 1989. He was a Markle Scholar and received a
Guggenheim Fellowship in recognition of his work and potential.
He served ASM as secretary, vice chair, and chair of the
Virology Division in the 1960s, and as a member of the editorial
board of Microbiological Reviews. He was a Fellow of the
American Academy of Microbiology.
Neal made one of the seminal discoveries in
microbiology shortly after his arrival in Seattle, namely that a
temperate bacterial virus could determine the production of
toxin by a host bacterium. This research, carried out with Corynebacterium
diphtheriae, began a long study of the relationship between
bacteriophages and their host. This widespread phenomenon,
termed lysogenic conversion, has been discovered in a wide
variety of both gram-positive and gram-negative organisms, where
it plays important roles in conferring new properties on host
cells. The toxin of Corynebacterium still serves as the
paradigm. In 1960, Neal took a sabbatical leave with A. Lwoff at
the Institut Pasteur, where he became interested in the role of
temperature in poliovirus replication. After returning home, he
studied the effect of temperature on the replication of X phage
and, in particular, on endolysin synthesis. This led to a series
of important published studies. However, his first love was Corynebacterium
and he returned to his work on corynebacterial phages, using
molecular and genetic techniques of increasing sophistication.
With his students, he isolated a naturally occurring plasmid
that was able to replicate in both Corynebacterium and Escherichia
coli, and also developed a DNA-mediated transformation
technique for introducing genes into Corynebacterium.
During his career, he published almost 75 papers, the vast
majority of which had one or two authors.
Neal was deeply committed to microbiological and
biological education at all levels. He was a superb
undergraduate teacher and a deeply respected mentor for
generations of graduate students. In 1971, he founded the Office
of Biology Education at the University of Washington and served
as its first director from 1971 to 1975. He was responsible for
instituting a new undergraduate biology curriculum that involved
coordinating the activities of different departments with
varying agendas. Although he showed himself to be a skilled
administrator and academic diplomat, and served as acting chair
of the Department of Microbiology for one year, he realized that
administration was not where he wished to devote his talents in
the future.
Neal was a scholar and a poet, with wide-ranging
interests beyond his microbiological career, including history,
political science, and philosophy. With all this talent and
diversity, he was always available to his colleagues and
students as a kind, calm, unfailingly courteous, and wise
friend, whose advice and counsel was sought by all who knew him.
His interest in poetry developed in the 1970s and became a major
focus after he retired. He wrote several hundred poems,
including some that were published. He told one of us that
everything he wished his beloved family to understand about him
was to be found in his poems. A number of them that we had not
previously seen were shared with us after his death. They range
from deeply philosophical, to whimsical, to very funny, and
serve as a wonderful window into the character and intellect of
this remarkable and much loved man.
The Department of Microbiology has established a
fund to honor his dedication to scholarship through prizes for
graduate student instructors who have demonstrated excellence in
teaching. Contributions may be sent to the Neal Groman Fund,
Department of Microbiology, Box 357242, University of
Washington, Seattle, WA 98195-7242
John C. Sherris
Eugene W. Nester
University of Washington, Seattle
Germaine Stanier (Cohen-Bazire) died on 9
May 2001. She was born Germaine Bazire in 1920 and educated in
Toulouse, France. Her father was a high school science teacher
and her mother a primary school teacher. After obtaining her
high school diploma (Baccalaureat), she studied at the Faculty
of Sciences of Toulouse. After the liberation of France, she
came to Paris and worked at the Institut Pasteur on the
mechanism of butyric and acetonobutylic fermentation, the
subject of her 1950 Ph.D. thesis.
She then joined the laboratory of Jacques Monod
at the Pasteur Institute and, in collaboration with M. Cohn and
A. M. Pappenheimer Jr., contributed actively to the heroic
period of research on the mechanisms of enzyme induction. Her
research on the specificity of induction led to the concept of
gratuitous inducers, and provided the experimental basis for the
concept of the `differential rate of enzyme synthesis.' Her
discovery, in 1953, with Jacques Monod of the specific
inhibition of the synthesis of tryptophan synthase by tryptophan,
along with a similar and simultaneous observation on the
specific inhibition of methionine synthase by methionine, led to
the concept of end-product repression of biosynthetic pathways.
In 1953, Germaine, thanks to her husband Roger
Stanier, discovered a new microbial world, that of the
photosynthetic prokaryotes. In Berkeley, Calif., she then
started research on the physiological, biochemical, and
structural properties of the principal groups of photosynthetic
prokaryotes: the purple and green anoxyphotobacteria and the
cyanobacteria. In particular, she became an excellent electron
microscopist. More than 60 articles and a large number of
unpublished results testified to the productivity and
originality of Germaine's research in these domains.
Some of her most important results and those
which had a wide scientific impact are as follows. (i) The very
strict regulation of photosynthetic pigments (bacteriochlorophyll
and carotenoids) by light and oxygen in members of the Athiorhodaceae:
repressed under aerobic conditions, their rate of synthesis is
inverse function of light intensity. (ii) The demonstration that
the "chromatophores," sites of the photosynthetic
activity in anoxyphotobacteria such as Chlorobium, are
not isolated particles but intracytoplasmic vesicles. (iii) The
discovery of the physiological role of carotenoids, rendered
possible by the isolation of a mutant strain of Rhodopseudomonas
spheroides: these pigments protect the organisms against the
damaging effects of photooxidation. (iv) Her research on
cyanobacteria, initiated in Berkeley and pursued after her
return to Paris in 1971 until her retirement, provided important
results on the structure and function of phycobiliproteins in
cyanobacteria. Immunological studies revealed the high degree of
evolutionary conservation of these photosynthetic antenna
proteins in cyanobacteria and red algae.
Many years ago, Germaine Stanier described the
beginning of her career by saying that she had been influenced
by four persons: Monsieur Vandel, her biology professor at the
University of Toulouse, Georges Cohen, her thesis supervisor,
Jacques Monod, her "master of thinking," and Andre
Lwoff, her "guardian angel." All through her
scientific career, Germaine Stanier kept her fascination for
biological phenomena, showing the same enthusiasm whether
studying organisms, their structure, or their molecules. What
was most admirable in Germaine was the courage with which she
continuously chose the difficult paths, or virgin territories,
and her insatiable desire to learn and to understand.
This very brief summary by no means reflects the
vast richness of Germaine's scientific career. Internationally
recognized as one of the specialists on photosynthetic
prokaryotes, Germaine Stanier had also exceptional human
qualities such as her generosity, intellectual honesty, and
moral integrity. The important role she played in science was
recognized in 1985 by her appointment as professor at the
Pasteur Institute and is still evidenced by the continuation of
the research unit, the "Unite des Cyanobacteries," a
laboratory that was created in 1971 at the Pasteur Institute as
the "Unité de Physiologie Microbienne" by Roger Y.
Stanier in 1971 and was headed by Germaine from 1982 until her
retirement in 1988. In addition to her academic interests, she
acted for many years as treasurer of the International Cell
Research Organization , in promoting training courses in the
developing countries.
Germaine is survived by a son from her first
marriage, Henri, by a daughter, Jane, and by seven
grandchildren.
Agnes Ullmann
Georges N. Cohen
Francois Jacob
Institut Pasteur
Paris, France
Branches
ASM Branches on the Web
The following ASM Branches have established sites on the World Wide
Web:
Alaska
Allegheny
Arizona
Connecticut
Valley
Eastern New
York
Eastern Pennsylvania
Florida
Hawaii
Illinois
Indiana
Kentucky-Tennessee
Maryland
Michigan
Missouri
New Jersey (Theobald Smith
Society)
New York City
North
Central
North
Carolina
Northern California
Northeast
Ohio
Puerto Rico
Rocky
Mountain
South
Carolina
South Central
Southeastern
Southern
California
Texas
Virginia
Washington, D.C.
Divisions
ASM Divisions on the Web
The following ASM Divisions have established sites on the World Wide
Web:
Division A, Antimicrobial
Chemotherapy
Division B, Microbial
Pathogenesis
Division C, Clinical
Microbiology
Division D, General Medical
Microbiology
Division E, Immunology
Division F,
Medical Mycology
Division G,
Mycoplasmology
Division I,
General Microbiology
Division K,
Microbial Physiology and Metabolism
Division M,
Bacteriophage
Division N, Microbial
Ecology
Division O,
Fermentation and Biotechnology
Division P, Food
Microbiology
Division Q, Environmental
and General Applied Microbiology
Division R, Systematic
& Evolutionary Microbiology
Division T, RNA
Viruses
Division U,
Mycobacteriology
Division W, Microbiology
Education
Division X,
Molecular, Cellular and General Microbiology of Eukaryotes
Division Y, Public
Health
Division Z, Animal
Health Microbiology
Members are encouraged to visit these Web pages, which are also
accessible through the Membership section of the ASM Web site.